Aldose reductase-IN-7

Aldose reductase-IN-7 (Compound 6k) targets Aldose reductase. Aldose reductase-IN-7 exhibits potent enzyme inhibitory activity (Ki = 0.186 ± 0.020 μM), showing superiority to Epalrestat (HY-66009), which is currently in clinical use. Aldose reductase-IN-7 is less cytotoxic and possesses potent anticancer activity[1].

Product Specifications

UNSPSC

12352005

Target

Aldose Reductase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/aldose-reductase-in-7.html

Solubility

10 mM in DMSO

Smiles

O=C(OCC)CN(C1=CC=C([N+]([O-])=O)C=C1C23OC(CC4=CC=C(OC)C=C4)=NN3)C2=O

Molecular Formula

C21H20N4O7

Molecular Weight

440.41

References & Citations

[1]Güleç Ö, et al. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies. Bioorg Chem. 2024 Apr;145:107221.